Clinical Trial Update: Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing eniluracil with 5-fluorouracil and leucovorin against capecitabine in metastatic breast cancer, sponsored by Adherex Technolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-fluorouracil (5-FU) (5-fluorouracil)
• Capecitabine (capecitabine)
• Eniluracil (eniluracil)
• Leucovorin (folinic acid)

Snippet

Sponsor: Adherex Technologies, Inc. | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN